ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

ClinicalTrials.gov ID: NCT06113445

Public ClinicalTrials.gov record NCT06113445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 6:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo

Study identification

NCT ID
NCT06113445
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
467 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Povorcitinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 28, 2023
Primary completion
Feb 23, 2026
Completion
Feb 23, 2027
Last update posted
Mar 22, 2026

2023 – 2027

United States locations

U.S. sites
34
U.S. states
16
U.S. cities
32
Facility City State ZIP Site status
Cahaba Dermatology Hoover Alabama 35244
University of California Irvine Irvine California 92697
Clinical Science Institute Clinical Research Specialists Inc Santa Monica California 90404
Cura Clinical Research Sherman Oaks California 91403
Sutter Health Palo Alto Medical Foundation Pamf Sunnyvale Center Sunnyvale California 94086
Renaissance Research Cape Coral Florida 33991
Encore Medical Research, Llc Hollywood Florida 33021
Savin Medical Group, Rc Miami Florida 33156
Skin Research of South Florida, Llc Miami Florida 33173
San Marcus Research Clinic Inc. Miami Lakes Florida 33014
Olympian Clinical Research Tampa Florida 33609
Forcare Clinical Research Tampa Florida 33613
Cleaver Medical Group Cumming Georgia 30040
Dermatology and Surgery Specialists of North Atlanta Marietta Georgia 30068
Pivotal Research Solutions Stonecrest Georgia 30038
Options Research Group, Llc Kokomo Indiana 46901
Allcutis Research, Llc Beverly Massachusetts 01915
Metro Boston Clinical Partners Brighton Massachusetts 02135-3511
Great Lakes Research Group Inc Bay City Michigan 48706
Wayne State University Physician Group Dermatology Dearborn Michigan 48124
Revival Research Institute, Llc Dermatology Troy Michigan 48084
Medisearch Clinical Trials Saint Joseph Missouri 64506
Jdr Dermatology Research Las Vegas Nevada 89148
Empire Dermatology East Syracuse New York 13057
Sadick Dermatology Sadick Research Group New York New York 10075
Derm Research Center of New York Inc Stony Brook New York 11790
Dermatology Associates of Plymouth Meeting Plymouth Meeting Pennsylvania 19462
International Clinical Research Tennessee Llc Murfreesboro Tennessee 37130
University of Texas Physicians - Bellaire Station Bellaire Texas 77401
Center For Clinical Studies Houston Texas 77004
Progressive Clinical Research San Antonio Texas 78213
Jordan Valley Dermatology Center West Jordan Utah 84088
Clinical Research Partners Llc Crp Richmond Forest Avenue Office Building Location Richmond Virginia 23226
Dermatology Specialists of Spokane Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06113445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 22, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06113445 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →